Davood Gheidari

5PUBLICATIONS
1CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsBasic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 03, 2026
Integrated experimental and computational study of a novel indenonaphthodiazepine[5.3.3]propellane as a potential inhibitor of Mcl-1.

|Nov 13, 2025
Synthesis of 3-(arylamino) quinazoline-2,4(1H,3H)-dione derivatives via TBHP/I2: Molecular docking, MD simulation, DFT, and pharmacological evaluation as MTH1 inhibitors.

Moeid Goudarzi Karim, Morteza Mehrdad, Davood Gheidari

|Aug 14, 2025
Synthesis, molecular docking, pharmacological evaluation, MD simulation, and DFT calculations of quinazolin-12-one derivatives as PDK1 inhibitors.

Zahra Sadeghian, Mohammad Bayat, Davood Gheidari

|Sep 12, 2024
Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents.

Fatemeh Aghahosseini, Mohammad Bayat, Zahra Sadeghian

|Mar 22, 2024
Synthesis, molecular docking analysis, molecular dynamic simulation, ADMET, DFT, and drug likeness studies: Novel Indeno[1,2-b]pyrrol-4(1H)-one as SARS-CoV-2 main protease inhibitors.

Davood Gheidari, Morteza Mehrdad, Mohammad Bayat

Pageof 1

Frequent Collaborators

3 joint publications

Mohammad Bayat